<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Comb Sci</journal-id><journal-id journal-id-type="iso-abbrev">ACS Comb Sci</journal-id><journal-id journal-id-type="publisher-id">co</journal-id><journal-id journal-id-type="coden">acsccc</journal-id><journal-title-group><journal-title>ACS Combinatorial Science</journal-title></journal-title-group><issn pub-type="ppub">2156-8952</issn><issn pub-type="epub">2156-8944</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28181791</article-id><article-id pub-id-type="pmc">5350607</article-id><article-id pub-id-type="doi">10.1021/acscombsci.7b00009</article-id><article-categories><subj-group><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Two Cycles with One Catch: Hydrazine in Ugi 4-CR
and Its Postcyclizations</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Wang</surname><given-names>Yuanze</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Patil</surname><given-names>Pravin</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Kurpiewska</surname><given-names>Katarzyna</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Kalinowska-Tluscik</surname><given-names>Justyna</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>D&#x000f6;mling</surname><given-names>Alexander</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label><institution>University
of Groningen</institution>, Department of Drug Design, A. Deusinglaan 1, 9713 AV Groningen, <country>The Netherlands</country></aff><aff id="aff2"><label>&#x02021;</label><institution>Jagiellonian
University</institution>, Faculty of Chemistry, Department
of Crystal Chemistry and Crystal Physics, Biocrystallography Group, Ingardena 3, 30-060 Krakow, <country>Poland</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Fax: <fax>(+31)503637582</fax>.
E-mail: <email>a.s.s.domling@rug.nl</email>. Website: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.drugdesign.nl">www.drugdesign.nl</uri>.</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>02</month><year>2017</year></pub-date><pub-date pub-type="ppub"><day>13</day><month>03</month><year>2017</year></pub-date><volume>19</volume><issue>3</issue><fpage>193</fpage><lpage>198</lpage><history><date date-type="received"><day>11</day><month>01</month><year>2017</year></date><date date-type="rev-recd"><day>07</day><month>02</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 American Chemical Society</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0010" id="ab-tgr1"/></p><p>Isocyanide-based
multicomponent reactions (IMCR) are by far the
most versatile reactions that can construct relatively complex molecules
by one-pot synthesis. More importantly, the development of post IMCR
modifications significantly improves the scaffold&#x02019;s diversity.
Here, we describe the use of <italic>N</italic>-Boc protected hydrazine
together with &#x003b1;-amino acid derived isocyanides in the Ugi tetrazole
reaction and its post cyclization under both acidic and basic conditions.
The cyclization in acidic conditions was conducted in a one pot fashion,
which give 7-aminotetrazolopyrazinone (<bold>6</bold>) and tetrazolotriazepinone
(<bold>7</bold>) cyclic products. The post cyclization under basic
condition could selectively afford Boc-protected 7-aminotetrazolopyrazinone
(<bold>8</bold>) products in yield of 38&#x02013;87%.</p></abstract><kwd-group><kwd>isocyanide-based multicomponent
reactions</kwd><kwd>hydrazine</kwd><kwd>post cyclization</kwd><kwd>tetrazole</kwd><kwd>one-pot synthesis</kwd><kwd>scaffolds diversity</kwd><kwd>European Lead Factory</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>co7b00009</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>co-2017-00009d</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Small molecules have
always been of great interest in medicinal
chemistry and chemical genetics. They can provide oral leads for drug
discovery while maintaining favorable cost-of-goods or can function
as probes to illuminate the mechanism of the biological processes
in the living systems.<sup><xref ref-type="bibr" rid="ref1">1</xref>&#x02212;<xref ref-type="bibr" rid="ref4">4</xref></sup> Such small molecule modulators are most commonly identified by high
throughput screening of large compound collections. The European Lead
Factory (ELF) supported by the Innovative Medicines Initiative (IMI)
is aiming to bring together 500&#x0202f;000 high-quality compounds
library from both academia and industry as the starting point for
innovative drug discovery.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> A general consensus
has emerged that library diversity, instead of library size, is a
crucial consideration. Multicomponent reaction (MCR) chemistry is
playing an important part in generating highly diverse compound libraries
as it is capable of assembling novel molecular scaffolds and generating
complex functionalization motifs in just a few steps on a short time
scale.<sup><xref ref-type="bibr" rid="ref6">6</xref>&#x02212;<xref ref-type="bibr" rid="ref8">8</xref></sup> Furthermore, the exploitation of MCR-product postcyclization
has also become a very popular strategy to generate complex skeletons.<sup><xref ref-type="bibr" rid="ref9">9</xref>&#x02212;<xref ref-type="bibr" rid="ref13">13</xref></sup></p><p>Ugi/de-Boc/cyclize (UDC) chemistry has been successfully used
in
Hulme group.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Recently, the application
of the mono-Boc protected hydrazine in the Ugi-tetrazole synthesis
has been first explored in our lab.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> Herein,
we show how &#x003b1;-amino acid derived isocyanides together with hydrazine
can be used to obtain bicyclic scaffolds. We envisioned that both
6-membered (<bold>6</bold>) and 7-membered (<bold>7</bold>) products
could be formed under the acidic conditions. Optimization of the protocol,
with a particular emphasis to selective obtainment of 6-membered rings,
as well as an application of the resulting compounds for further diversification,
are described.</p></sec><sec id="sec2"><title>Results and Discussion</title><p>The reaction
of Boc-hydrazine <bold>1</bold> with acetone <bold>2a</bold>, isocyanide <bold>3a</bold>, and trimethylsilyl azide <bold>4</bold> was performed
in methanol at ambient temperature for 18
h which afforded a moderate yield of <bold>5a</bold> (45%) (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). It is well-known
that Lewis acids could help the activation of the Schiff base and
its formation which can be the rate-limiting step in the Ugi-4CR.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Hence, we initiated our work by screening various
Lewis acids such as CF<sub>3</sub>SO<sub>3</sub>Li, CF<sub>3</sub>SO<sub>3</sub>Ag, CF<sub>3</sub>SO<sub>3</sub>K, (CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>Mg, (CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>Zn, ZnCl<sub>2</sub>, SnCl<sub>2</sub>, (CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub>In, and (CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub>Al
as the catalyst in the Ugi-4CR reaction (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Synthesis of Ugi-Adduct (<bold>5a</bold>)</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0001" id="gr1" position="float"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Screening of the
Lewis Acid Catalysts
for Ugi-Tetrazole Adduct</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center">catalyst</th><th style="border:none;" align="center" char=".">conc. (equiv)</th><th style="border:none;" align="center" char=".">yield (%)<xref rid="t1fn1" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="center">-</td><td style="border:none;" align="center" char=".">-</td><td style="border:none;" align="char" char=".">45</td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="left">ZnCl<sub>2</sub></td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">72</td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="left">SnCl<sub>2</sub></td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">60</td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="left">(CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>Zn</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">62</td></tr><tr><td style="border:none;" align="left">5</td><td style="border:none;" align="left">CF<sub>3</sub>SO<sub>3</sub>Ag</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">43</td></tr><tr><td style="border:none;" align="left">6</td><td style="border:none;" align="left">CF<sub>3</sub>SO<sub>3</sub>K</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">47</td></tr><tr><td style="border:none;" align="left"><bold>7</bold></td><td style="border:none;" align="left"><bold>(CF</bold><sub><bold>3</bold></sub><bold>SO</bold><sub><bold>3</bold></sub><bold>)</bold><sub><bold>2</bold></sub><bold>Mg</bold></td><td style="border:none;" align="char" char="."><bold>0.1</bold></td><td style="border:none;" align="char" char="."><bold>75</bold></td></tr><tr><td style="border:none;" align="left">8</td><td style="border:none;" align="left">CF<sub>3</sub>SO<sub>3</sub>Li</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">53</td></tr><tr><td style="border:none;" align="left">9</td><td style="border:none;" align="left">(CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub>In</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">38</td></tr><tr><td style="border:none;" align="left">10</td><td style="border:none;" align="left">(CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub>Al</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">47</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Isolated yield.</p></fn></table-wrap-foot></table-wrap><p>We found
that divalent Lewis acid catalysts afforded high yields,
(CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>Mg was found to be the best
catalysts affording 75% yield of <bold>5a</bold>. ZnCl<sub>2</sub> gave a similar good yield of 72%. In addition, (CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>Zn and SnCl<sub>2</sub> resulted in slightly
lower yields (62% and 60%). In contrast, poorer yields were observed
in the reactions catalyzed by other commonly used Lewis acids. Hence,
(CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>Mg was the Lewis acid catalyst
of choice for the subsequent explorations.</p><p>With the optimal
catalyst for Ugi-4CR in hand, the conditions for
postcyclization were further optimized. At first, we tried to cyclize
the Ugi-adduct under acidic conditions in one pot (<xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>). We speculated that it is
possible to form both 6-membered (<bold>6</bold>) and 7-membered (<bold>7</bold>) cyclized products as the Boc-protecting group will be removed
in acidic condition. Although the 7-membered product suffered from
more strain during the ring formation than the 6-membered product,
the exposed primary amine would be also highly interesting for further
transformations.</p><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>One-Pot Cyclization of Ugi-Adduct under Acidic Condition</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0002" id="gr2" position="float"/></fig><p>We commenced our one pot postcyclization
under acidic conditions
using Ugi-adduct <bold>5a</bold>. Four different acids: trifluoroacetic
acid, acetyl chloride, 6 M aqueous hydrochloric acid, and 2 M methanolic
hydrochloric acid were screened (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Results showed that two equivalents of trifluoroacetic
acid afforded poor yields of <bold>6a</bold> (10%) and traces of <bold>7a</bold>. When 6 M aqueous hydrochloric acid solutions was used
as the solvent, a 33% yield of the 6-membered product (<bold>6a)</bold> was afforded. Interestingly, two equivalent of acetyl chloride in
methanol as solvent gave 36% yield of the 6-membered product (<bold>6a</bold>), as well as little amount of 7-membered product (<bold>7a</bold>, 5% yield). Surprisingly, when we used 2 M methanolic hydrochloric
acid as solvent, the yield of 6-membered (<bold>6a)</bold> product
significantly increased to 64% and minor 7-membered (<bold>7a</bold>) product (6% yield) was formed. Hence, 2 M methanolic hydrochloric
acid was chosen as the acid for postcyclization. Furthermore, we explored
the possibility to accomplish the overall 2-step sequence in a one-pot
fashion. The unpurified Ugi-adduct obtained was directly treated with
2 M methanolic hydrochloric acid. We were pleased to observe that
43% of yield 6-membered product <bold>6a</bold> and 6% yield of 7-membered
product <bold>7a</bold> could be obtained in the one-pot procedure.
After these interesting results, the generality of this one-pot procedure
was then explored by varying the isocyanide and oxo-components (<xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Screening of Acidic Conditions for
Post-cyclization</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">&#x000a0;</th><th colspan="2" align="center" char=".">yield
(%)<xref rid="t2fn1" ref-type="table-fn">a</xref><hr/></th></tr><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center">acid, solvent</th><th style="border:none;" align="center">amount, time</th><th style="border:none;" align="center" char="."><bold>6a</bold></th><th style="border:none;" align="center" char="."><bold>7a</bold></th></tr></thead><tbody><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="left">TFA, MeOH</td><td style="border:none;" align="left">2 equiv., 18 h</td><td style="border:none;" align="char" char=".">10</td><td style="border:none;" align="left" char=".">traces</td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="left">6 M aq. HCl</td><td style="border:none;" align="left">5 mL,
18 h</td><td style="border:none;" align="char" char=".">33</td><td style="border:none;" align="left" char=".">traces</td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="left">acetyl chloride, MeOH</td><td style="border:none;" align="left">2
equiv., 18 h</td><td style="border:none;" align="char" char=".">36</td><td style="border:none;" align="char" char=".">5</td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="left">2 M HCl in MeOH</td><td style="border:none;" align="left">5 mL, 4 h</td><td style="border:none;" align="char" char=".">64</td><td style="border:none;" align="char" char=".">6</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Isolated yield.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Typical Structures
and Yields of Post-Cyclization
Product under Acid Condition</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0005" id="fx1" position="float"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0006" id="fx2" position="float"/><table-wrap-foot><fn id="t3fn1"><label>a</label><p>One-pot isolated yields.</p></fn><fn id="t3fn2"><label>b</label><p>dr ratio = 25:1.</p></fn><fn id="t3fn3"><label>c</label><p>dr ratio = 1:1.</p></fn></table-wrap-foot></table-wrap><p>Various derivatives of methyl glycine isocyanides along with ketones
and aldehydes were synthesized. When we used methyl glycine isocyanides
with acetone, 6-memberd ring <bold>6b</bold> was obtained in 33% yield.
Surprisingly, with cyclohexanone we observed only a minor amount of
6-membered ring <bold>6c</bold> (7% yield) along with spiro-7-membered
ring <bold>7c</bold> (34% yield). A similar trend was observed with
isovaleraldehyde, that gave 7-membered ring <bold>7d</bold> in 29%
yield accompanied by <bold>6d</bold> in only trace amount. With hydrocinnamaldehyde
(entry 5), we obtained <bold>6e</bold> in 27% yield along with 10%
yield of 7-memberd ring (<bold>7e</bold>). Similar results were obtained
with isobutyraldehyde (entry 6), in this case we obtained 24% yield
of <bold>6f</bold> and 10% yield of <bold>7f</bold>. In addition,
the isocyanide derived from methyl phenylalaninate was used in combination
with various oxo components. With cyclopropanecarboxaldehyde (entry
7) and acetone (entry 8) we obtained only 6-membered ring <bold>6g</bold> and <bold>6h</bold> in 23% and 30% yield, respectively. Cyclopentanone
(entry 10), hydrocinnamaldehyde (entry 11) and isobutyraldehyde (entry
12) gave only 6-memberd ring <bold>6j</bold> (34% yield), <bold>6k</bold> (15% yield) and <bold>6l</bold> (35% yield). In case of <bold>6k</bold> and <bold>6l</bold>, we observed the diastereomeric mixtures in
25:1 and 1:1 ratio, respectively. Cyclohexanone gave <bold>6i</bold> (16% yield) and <bold>7i</bold> (26% yield). Interestingly, in the
final 7-membered product <bold>7i</bold> we observed a mixture of
two ring-flip conformers in 1:1 ratio in the NMR spectra. A similar
phenomenon is often observed in the related 7-membered benzodiazepines
based on ring flipping and axial and equatorial orientation of bulky
substituents. Furthermore, we tested the isocyanide derived from valine
methyl ester with various oxo-components like acetone and cyclohexanone.
Surprisingly, we were able to isolate only the 6-membered ring <bold>6m</bold> in 38% yield with acetone and exclusively the 7-membered
ring <bold>7n</bold> in 40% yield with cyclohexanone. With cyclopentanone
(entry 15) we obtained 6-membered and 7-membered ring <bold>6o</bold> and <bold>7o</bold> in 38% and 6% yield, respectively. Although
the overall yield of the one-pot reaction under acidic condition is
relatively low, we were surprised to find that both 6-membered and
7-membered products were obtained. As we can see from cyclization
products <bold>6e</bold> and <bold>7e</bold>, <bold>6f</bold> and <bold>7f</bold>, and <bold>6o</bold> and <bold>7o</bold>, 6-membered product
was formed as the major product and the 7-membered product was formed
in less than 10% yield. Notably, when cyclohexanone was used as the
oxo-component, the 7-membered ring was observed as the major product
(<bold>7c</bold>, <bold>7i</bold>, and <bold>7n</bold>). In general
the yields and selectivity of the reaction under acidic conditions
was unsatisfactory. Therefore, we tried to cyclize the Ugi-adduct
under basic conditions (<xref rid="sch3" ref-type="scheme">Scheme <xref rid="sch3" ref-type="scheme">3</xref></xref>, <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>).</p><fig id="sch3" position="float"><label>Scheme 3</label><caption><title>Cyclization under Basic Conditions</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0003" id="gr3" position="float"/></fig><table-wrap id="tbl4" position="float"><label>Table 4</label><caption><title>Screening of Basic Conditions for
Post-cyclization</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center">catalyst</th><th style="border:none;" align="center" char=".">conc. (equiv)</th><th style="border:none;" align="center" char=".">time
(h)</th><th style="border:none;" align="center" char=".">yield (%)<xref rid="t4fn1" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="left">DIPEA</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">20</td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="left">DIPEA</td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">12</td><td style="border:none;" align="char" char=".">25</td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="left">NaOCH<sub>3</sub></td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">33</td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="left">NaOCH<sub>3</sub></td><td style="border:none;" align="char" char=".">0.1</td><td style="border:none;" align="char" char=".">12</td><td style="border:none;" align="char" char=".">40</td></tr><tr><td style="border:none;" align="left"><bold>5</bold></td><td style="border:none;" align="left"><bold>NaOCH</bold><sub><bold>3</bold></sub></td><td style="border:none;" align="char" char="."><bold>1</bold></td><td style="border:none;" align="char" char="."><bold>1</bold></td><td style="border:none;" align="char" char="."><bold>86</bold></td></tr><tr><td style="border:none;" align="left">6</td><td style="border:none;" align="left">NaOCH<sub>3</sub></td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">80</td></tr></tbody></table><table-wrap-foot><fn id="t4fn1"><label>a</label><p>Isolated
yield.</p></fn></table-wrap-foot></table-wrap><p>As the Boc-protecting
group is generally stable under basic conditions,
only the 6-membered products with the Boc-group on are expected to
be formed. Initially, two bases (DIPEA and NaOCH<sub>3</sub>) which
are often used in cyclization chemistry were evaluated. It was found
that when they were used in catalytic amounts, very poor yield was
observed in both cases after 1h. In addition, prolonging the reaction
time from 1 to 12 h had little effect either. As NaOCH<sub>3</sub> has given higher yield than DIPEA, we further increased the amount
of NaOCH<sub>3</sub> to one equivalent, which significantly improved
the reaction yield to 86%. However, increasing the base amount to
two equivalents failed to further improve the reaction yield.</p><p>The results of the cyclization under basic condition are summarized
in <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>. We tested
different methyl glycine isocyanide derivatives obtained from various
amino acids in Ugi-tetrazole reaction with the various oxo-components.
To avoid the formations of diastereomeric mixture after the post modification
on Ugi-adducts, we selected symmetric ketones as oxo-components. Interestingly,
with magnesium triflate as Lewis acid catalyst in the Ugi-tetrazole
reaction, good to excellent yields of adducts (<bold>5a</bold>&#x02013;<bold>5l</bold>, 56&#x02013;90%) was obtained. These pure isolated Ugi-tetrazole
adducts were subjected to cyclization with sodium methoxide (1 equiv)
in methanol (0.5 M) at room temperature. All Ugi-tetrazole adducts
(<bold>5a&#x02013;5l</bold>) gave 6-membered cyclized product (<bold>8a</bold>&#x02013;<bold>8l</bold>) in moderate to excellent yields
(38&#x02013;87%). Furthermore, we wanted to develop this reaction sequence
in one pot. To test this strategy, we selected the methyl leucine
isocyanide with acetone as an oxo-component, mono-Boc hydrazine and
TMSN<sub>3</sub>. We observed the Ugi tetrazole adduct formation was
good by SFC-MS and TLC analysis. After the addition of sodium methoxide
in the reaction mixture for basic cyclization, we observed multiple
product formation. The major side product was the hydrolyzed methyl
ester of the Ugi-tetrazole adducts to the corresponding acids; however, <bold>8a</bold> was isolated only in 41% yield.</p><table-wrap id="tbl5" position="float"><label>Table 5</label><caption><title>Typical
Structures and Yields of Post-cyclization
Product under Basic Condition</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0007" id="fx3" position="float"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0008" id="fx4" position="float"/><table-wrap-foot><fn id="t5fn1"><label>a</label><p>Isolated yields.</p></fn><fn id="t5fn2"><label>b</label><p><italic>N</italic>-Boc rotamers.</p></fn></table-wrap-foot></table-wrap><p>As we observed the one pot postcyclization under acidic
condition
using Ugi-adduct <bold>5</bold> was poor yielding to compounds <bold>6</bold>. We further deprotected the compounds <bold>8</bold> under
acidic condition using 2 M methanolic hydrochloric acid at room temperature
for 18h (<xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>).
We obtained exo-NHBoc deprotected compounds as hydrochloric salts
(<bold>9</bold>) in excellent yields after evaporation of solvents.</p><table-wrap id="tbl6" position="float"><label>Table 6</label><caption><title>Deprotection of Compound <bold>8</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0009" id="fx5" position="float"/></table-wrap><p>To further support structural
proof, we were also able to grow
crystals of some Ugi-adducts, 6-membered products and 7-membered products
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Crystal structures
of <bold>5a</bold>, <bold>5d</bold>, <bold>7e</bold>, <bold>6h</bold> and <bold>6j</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0011" id="gr5" position="float"/></fig><p>Lastly, the diversity application
of the free exo-NH<sub>2</sub> group in compounds <bold>6a</bold> for
biological studies was accomplished
by synthesizing some derivatives through acylation, sulfonylation
and thiourea formation (<xref rid="sch4" ref-type="scheme">Scheme <xref rid="sch4" ref-type="scheme">4</xref></xref>). Compounds <bold>6a</bold> reacted with 1.2 equiv of acryloyl
chloride to give compound <bold>10</bold> in 78% yields. Upon treatment
with 4-chlorobenzoyl chloride in DCE under reflux, compound <bold>11</bold> (75% yield) was afforded. The reaction of <bold>6a</bold> with 4-methylbenzenesulfonyl chloride led to <bold>12</bold> in
66% yield. In addition, <bold>6a</bold> was also subjected to phenyl
thioisocyanate with pyridine in DCE to give <bold>13</bold> in 56%
yield.</p><fig id="sch4" position="float"><label>Scheme 4</label><caption><title>Application of the Primary Amine in Ugi-Adduct <bold>6a</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co-2017-00009d_0004" id="gr4" position="float"/></fig></sec><sec id="sec3"><title>Conclusions</title><p>In
summary, we described here the application of mono-Boc-protected
hydrazine in the Ugi tetrazole synthesis and its postcyclization.
Both 7-aminotetrazolopyrazinone (<bold>6</bold>) and tetrazolotriazepinone
(<bold>7</bold>) products were afforded in one-pot under acidic conditions.
Under basic condition, Boc-protected 7-aminotetrazolopyrazinone (<bold>8</bold>) products were obtained in good to excellent yield. The
exposed free primary amine could be further used as the building block
to synthesize more complex compounds.</p></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acscombsci.7b00009">10.1021/acscombsci.7b00009</ext-link>.<list id="silist" list-type="simple"><list-item><p>Experimental procedures,
compound data, NMR spectra,
HRMS, and crystal structure determinations (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscombsci.7b00009/suppl_file/co7b00009_si_001.pdf">PDF</ext-link>)</p></list-item><list-item><p>Crystallographic information file
for compound <bold>5a</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscombsci.7b00009/suppl_file/co7b00009_si_002.cif">CIF</ext-link>)</p></list-item><list-item><p>Crystallographic information file for compound <bold>5d</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscombsci.7b00009/suppl_file/co7b00009_si_003.cif">CIF</ext-link>)</p></list-item><list-item><p>Crystallographic information file for compound <bold>6h</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscombsci.7b00009/suppl_file/co7b00009_si_004.cif">CIF</ext-link>)</p></list-item><list-item><p>Crystallographic
information file for compound <bold>6j</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscombsci.7b00009/suppl_file/co7b00009_si_005.cif">CIF</ext-link>)</p></list-item><list-item><p>Crystallographic information
file for compound <bold>7e</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscombsci.7b00009/suppl_file/co7b00009_si_006.cif">CIF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co7b00009_si_001.pdf"><caption><p>co7b00009_si_001.pdf</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile2"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co7b00009_si_002.cif"><caption><p>co7b00009_si_002.cif</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile3"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co7b00009_si_003.cif"><caption><p>co7b00009_si_003.cif</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile4"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co7b00009_si_004.cif"><caption><p>co7b00009_si_004.cif</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile5"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co7b00009_si_005.cif"><caption><p>co7b00009_si_005.cif</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile6"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="co7b00009_si_006.cif"><caption><p>co7b00009_si_006.cif</p></caption></media></supplementary-material></sec><notes notes-type="COI-statement" id="notes-2"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>This work
was financially supported (A.D.) by the NIH (2R01GM097082-05),
the Innovative Medicines Initiative (Grant Agreement No. 115489),
and received funding from the European Union&#x02019;s Horizon 2020
research and innovation program under MSC ITN &#x0201c;Accelerated
Early stage drug discovery&#x0201d; (AEGIS), Grant Agreement No. 675555.
K. K, K-T. J supported by the European Regional Development Fund in
the framework of the Polish Innovation Economy Operational Program
(Contract No. POIG.02.01.00-12-023/08). We acknowledge the China Scholarship
Council for supporting Y.W.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Adams</surname><given-names>J. L.</given-names></name>; <name><surname>Smothers</surname><given-names>J.</given-names></name>; <name><surname>Srinivasan</surname><given-names>R.</given-names></name>; <name><surname>Hoos</surname><given-names>A.</given-names></name>
<article-title>Big opportunities for
small molecules in immuno-oncology</article-title>. <source>Nat. Rev.
Drug Discovery</source>
<year>2015</year>, <volume>14</volume>, <fpage>603</fpage>&#x02013;<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1038/nrd4596</pub-id>.<pub-id pub-id-type="pmid">26228631</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Aeluri</surname><given-names>M.</given-names></name>; <name><surname>Chamakuri</surname><given-names>S.</given-names></name>; <name><surname>Dasari</surname><given-names>B.</given-names></name>; <name><surname>Guduru</surname><given-names>S. K.</given-names></name>; <name><surname>Jimmidi</surname><given-names>R.</given-names></name>; <name><surname>Jogula</surname><given-names>S.</given-names></name>; <name><surname>Arya</surname><given-names>P.</given-names></name>
<article-title>Small molecule modulators of protein&#x02013;protein
interactions: selected case studies</article-title>. <source>Chem. Rev.</source>
<year>2014</year>, <volume>114</volume>, <fpage>4640</fpage>&#x02013;<lpage>4694</lpage>. <pub-id pub-id-type="doi">10.1021/cr4004049</pub-id>.<pub-id pub-id-type="pmid">24673632</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Doyle</surname><given-names>S. K.</given-names></name>; <name><surname>Pop</surname><given-names>M. S.</given-names></name>; <name><surname>Evans</surname><given-names>H. L.</given-names></name>; <name><surname>Koehler</surname><given-names>A. N.</given-names></name>
<article-title>Advances in discovering
small molecules to probe protein function in a systems context</article-title>. <source>Curr. Opin. Chem. Biol.</source>
<year>2016</year>, <volume>30</volume>, <fpage>28</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2015.10.032</pub-id>.<pub-id pub-id-type="pmid">26615565</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Arkin</surname><given-names>M. R.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>; <name><surname>Wells</surname><given-names>J. A.</given-names></name>
<article-title>Small-molecule inhibitors
of protein-protein
interactions: progressing toward the reality</article-title>. <source>Chem. Biol.</source>
<year>2014</year>, <volume>21</volume>, <fpage>1102</fpage>&#x02013;<lpage>1114</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2014.09.001</pub-id>.<pub-id pub-id-type="pmid">25237857</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5a"><label>a</label><name><surname>Besnard</surname><given-names>J.</given-names></name>; <name><surname>Jones</surname><given-names>P. S.</given-names></name>; <name><surname>Hopkins</surname><given-names>A. L.</given-names></name>; <name><surname>Pannifer</surname><given-names>A. D.</given-names></name>
<article-title>The joint
european compound library: Boosting precompetitive research</article-title>. <source>Drug Discovery Today</source>
<year>2015</year>, <volume>20</volume>, <fpage>181</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2014.08.014</pub-id>.<pub-id pub-id-type="pmid">25205347</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5b"><label> b</label><name><surname>Hamza</surname><given-names>D.</given-names></name>; <name><surname>Kalliokoski</surname><given-names>T.</given-names></name>; <name><surname>Pouwer</surname><given-names>K.</given-names></name>; <name><surname>Morgentin</surname><given-names>R.</given-names></name>; <name><surname>Nelson</surname><given-names>A.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>G.</given-names></name>; <name><surname>Piechot</surname><given-names>D.</given-names></name>; <name><surname>Tzalis</surname><given-names>D.</given-names></name>; et al. <article-title>Expansion of chemical space for collaborative lead generation and
drug discovery: the European Lead Factory Perspective</article-title>. <source>Drug Discovery Today</source>
<year>2015</year>, <volume>20</volume>, <fpage>1310</fpage>&#x02013;<lpage>1316</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2015.09.009</pub-id>.<pub-id pub-id-type="pmid">26429298</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5c"><label> c</label><name><surname>Mullard</surname><given-names>A.</given-names></name>
<article-title>European lead
factory opens for business</article-title>. <source>Nat. Rev. Drug Discovery</source>
<year>2013</year>, <volume>12</volume>, <fpage>173</fpage>&#x02013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3956</pub-id>.<pub-id pub-id-type="pmid">23449292</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5d"><label> d</label><name><surname>Nelson</surname><given-names>A.</given-names></name>; <name><surname>Roche</surname><given-names>D.</given-names></name>
<article-title>Innovative approaches to the design
and synthesis of small molecule libraries</article-title>. <source>Bioorg.
Med. Chem.</source>
<year>2015</year>, <volume>23</volume>, <fpage>2613</fpage><pub-id pub-id-type="doi">10.1016/j.bmc.2015.02.046</pub-id>.<pub-id pub-id-type="pmid">25766626</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5e"><label> e</label><name><surname>Paillard</surname><given-names>G.</given-names></name>; <name><surname>Cochrane</surname><given-names>P.</given-names></name>; <name><surname>Jones</surname><given-names>P. S.</given-names></name>; <name><surname>Caracoti</surname><given-names>A.</given-names></name>; <name><surname>van Vlijmen</surname><given-names>H.</given-names></name>; <name><surname>Pannifer</surname><given-names>A. D.</given-names></name>
<article-title>The ELF Honest Data Broker: informatics
enabling public&#x02013;private collaboration in a precompetitive arena</article-title>. <source>Drug Discovery Today</source>
<year>2016</year>, <volume>21</volume>, <fpage>97</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2015.11.005</pub-id>.<pub-id pub-id-type="pmid">26608890</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Domling</surname><given-names>A.</given-names></name>
<article-title>Recent developments
in isocyanide based multicomponent reactions in applied chemistry</article-title>. <source>Chem. Rev.</source>
<year>2006</year>, <volume>106</volume>, <fpage>17</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1021/cr0505728</pub-id>.<pub-id pub-id-type="pmid">16402771</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>D&#x000f6;mling</surname><given-names>A.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>
<article-title>Chemistry and biology of multicomponent
reactions</article-title>. <source>Chem. Rev.</source>
<year>2012</year>, <volume>112</volume>, <fpage>3083</fpage>&#x02013;<lpage>3135</lpage>. <pub-id pub-id-type="doi">10.1021/cr100233r</pub-id>.<pub-id pub-id-type="pmid">22435608</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="book" id="cit8"><person-group person-group-type="editor"><name><surname>Zhu</surname><given-names>J.</given-names></name>, <name><surname>Bienayme</surname><given-names>H.</given-names></name></person-group>, Eds. <source>Multicomponent
Reactions</source>; <publisher-name>Wiley-VCH</publisher-name>: <publisher-loc>Weinheim, Germany</publisher-loc>, <year>2005</year>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Sinha</surname><given-names>M. K.</given-names></name>; <name><surname>Khoury</surname><given-names>K.</given-names></name>; <name><surname>Herdtweck</surname><given-names>E.</given-names></name>; <name><surname>D&#x000f6;mling</surname><given-names>A.</given-names></name>
<article-title>Various cyclization
scaffolds by a truly Ugi 4-CR</article-title>. <source>Org. Biomol.
Chem.</source>
<year>2013</year>, <volume>11</volume>, <fpage>4792</fpage>&#x02013;<lpage>4796</lpage>. <pub-id pub-id-type="doi">10.1039/c3ob40523k</pub-id>.<pub-id pub-id-type="pmid">23760036</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Patil</surname><given-names>P.</given-names></name>; <name><surname>Khoury</surname><given-names>K.</given-names></name>; <name><surname>Herdtweck</surname><given-names>E.</given-names></name>; <name><surname>D&#x000f6;mling</surname><given-names>A.</given-names></name>
<article-title>A Universal
Isocyanide for Diverse Heterocycle Syntheses</article-title>. <source>Org. Lett.</source>
<year>2014</year>, <volume>16</volume>, <fpage>5736</fpage>&#x02013;<lpage>5739</lpage>. <pub-id pub-id-type="doi">10.1021/ol5024882</pub-id>.<pub-id pub-id-type="pmid">25351886</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Patil</surname><given-names>P.</given-names></name>; <name><surname>Khoury</surname><given-names>K.</given-names></name>; <name><surname>Herdtweck</surname><given-names>E.</given-names></name>; <name><surname>D&#x000f6;mling</surname><given-names>A.</given-names></name>
<article-title>MCR synthesis
of a tetracyclic tetrazole scaffold</article-title>. <source>Bioorg.
Med. Chem.</source>
<year>2015</year>, <volume>23</volume>, <fpage>2699</fpage>&#x02013;<lpage>2715</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2014.12.021</pub-id>.<pub-id pub-id-type="pmid">25630499</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Zarganes-Tzitzikas</surname><given-names>T.</given-names></name>; <name><surname>Patil</surname><given-names>P.</given-names></name>; <name><surname>Khoury</surname><given-names>K.</given-names></name>; <name><surname>Herdtweck</surname><given-names>E.</given-names></name>; <name><surname>D&#x000f6;mling</surname><given-names>A.</given-names></name>
<article-title>Concise Synthesis of Tetrazole&#x02013;Ketopiperazines
by Two Consecutive Ugi Reactions</article-title>. <source>Eur. J. Org.
Chem.</source>
<year>2015</year>, <volume>2015</volume>, <fpage>51</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201403401</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Erb</surname><given-names>W.</given-names></name>; <name><surname>Neuville</surname><given-names>L.</given-names></name>; <name><surname>Zhu</surname><given-names>J.</given-names></name>
<article-title>Ugi-post functionalization, from
a single set of Ugi-adducts to two distinct heterocycles by microwave-assisted
palladium-catalyzed cyclizations: tuning the reaction pathways by
ligand switch</article-title>. <source>J. Org. Chem.</source>
<year>2009</year>, <volume>74</volume>, <fpage>3109</fpage>&#x02013;<lpage>3115</lpage>. <pub-id pub-id-type="doi">10.1021/jo900210x</pub-id>.<pub-id pub-id-type="pmid">19284772</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14a"><label>a</label><name><surname>Tempest</surname><given-names>P.</given-names></name>; <name><surname>Ma</surname><given-names>L.</given-names></name>; <name><surname>Thomas</surname><given-names>S.</given-names></name>; <name><surname>Hua</surname><given-names>Z.</given-names></name>; <name><surname>Kelly</surname><given-names>M. G.</given-names></name>; <name><surname>Hulme</surname><given-names>C.</given-names></name>
<article-title>Two-step solution-phase synthesis
of novel benzimidazoles utilizing a UDC (Ugi/de-Boc/cyclize) strategy</article-title>. <source>Tetrahedron Lett.</source>
<year>2001</year>, <volume>42</volume>, <fpage>4959</fpage>&#x02013;<lpage>4962</lpage>. <pub-id pub-id-type="doi">10.1016/S0040-4039(01)00919-4</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit14b"><label> b</label><name><surname>Nixey</surname><given-names>T.</given-names></name>; <name><surname>Kelly</surname><given-names>M.</given-names></name>; <name><surname>Semin</surname><given-names>D.</given-names></name>; <name><surname>Hulme</surname><given-names>C.</given-names></name>
<article-title>Short solution
phase preparation of fused azepine-tetrazoles via a UDC (Ugi/de-Boc/cyclize)
strategy</article-title>. <source>Tetrahedron Lett.</source>
<year>2002</year>, <volume>43</volume>, <fpage>3681</fpage>&#x02013;<lpage>3684</lpage>. <pub-id pub-id-type="doi">10.1016/S0040-4039(02)00636-6</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit14c"><label> c</label><name><surname>Gunawan</surname><given-names>S.</given-names></name>; <name><surname>Ayaz</surname><given-names>M.</given-names></name>; <name><surname>De Moliner</surname><given-names>F.</given-names></name>; <name><surname>Frett</surname><given-names>B.</given-names></name>; <name><surname>Kaiser</surname><given-names>C.</given-names></name>; <name><surname>Patrick</surname><given-names>N.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Hulme</surname><given-names>C.</given-names></name>
<article-title>Synthesis of tetrazolo-fused benzodiazepines and benzodiazepinones
by a two-step protocol using an Ugi-azide reaction for initial diversity
generation</article-title>. <source>Tetrahedron</source>
<year>2012</year>, <volume>68</volume>, <fpage>5606</fpage>&#x02013;<lpage>5611</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2012.04.068</pub-id>.<pub-id pub-id-type="pmid">22923851</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit14d"><label> d</label><name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Ayaz</surname><given-names>M.</given-names></name>; <name><surname>Cappelli</surname><given-names>A. A.</given-names></name>; <name><surname>Hulme</surname><given-names>C.</given-names></name>
<article-title>General one-pot,
two-step protocol accessing a range of novel polycyclic heterocycles
with high skeletal diversity</article-title>. <source>ACS Comb. Sci.</source>
<year>2012</year>, <volume>14</volume>, <fpage>460</fpage>&#x02013;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1021/co300046r</pub-id>.<pub-id pub-id-type="pmid">22746181</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Patil</surname><given-names>P.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Kurpiewska</surname><given-names>K.</given-names></name>; <name><surname>Kalinowska-T&#x00142;u&#x0015b;cik</surname><given-names>J.</given-names></name>; <name><surname>D&#x000f6;mling</surname><given-names>A.</given-names></name>
<article-title>Hydrazine
in the Ugi Tetrazole Reaction</article-title>. <source>Synthesis</source>
<year>2016</year>, <volume>48</volume>, <fpage>1122</fpage>&#x02013;<lpage>1130</lpage>. <pub-id pub-id-type="doi">10.1055/s-0035-1561353</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16a"><label>a</label><name><surname>Godet</surname><given-names>T.</given-names></name>; <name><surname>Bonvin</surname><given-names>Y.</given-names></name>; <name><surname>Vincent</surname><given-names>G.</given-names></name>; <name><surname>Merle</surname><given-names>D.</given-names></name>; <name><surname>Thozet</surname><given-names>A.</given-names></name>; <name><surname>Ciufolini</surname><given-names>M. A.</given-names></name>
<article-title>Titanium
catalysis in the Ugi reaction of &#x003b1;-amino acids with aromatic
aldehydes</article-title>. <source>Org. Lett.</source>
<year>2004</year>, <volume>6</volume>, <fpage>3281</fpage>&#x02013;<lpage>3284</lpage>. <pub-id pub-id-type="doi">10.1021/ol048850x</pub-id>.<pub-id pub-id-type="pmid">15355032</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit16b"><label> b</label><name><surname>Dai</surname><given-names>W. M.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>
<article-title>Lewis acid-catalyzed formation of
Ugi four-component reaction product from Passerini three-component
reaction system without an added amine</article-title>. <source>Tetrahedron</source>
<year>2007</year>, <volume>63</volume>, <fpage>12866</fpage>&#x02013;<lpage>12876</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2007.10.050</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit16c"><label> c</label><name><surname>Bonger</surname><given-names>K. M.</given-names></name>; <name><surname>Wennekes</surname><given-names>T.</given-names></name>; <name><surname>Filippov</surname><given-names>D. V.</given-names></name>; <name><surname>Lodder</surname><given-names>G.</given-names></name>; <name><surname>van der Marel</surname><given-names>G. A.</given-names></name>; <name><surname>Overkleeft</surname><given-names>H. S.</given-names></name>
<article-title>The Effect of Lewis Acids on the
Stereochemistry in the Ugi Three-Component Reaction with D-lyxo-Pyrroline</article-title>. <source>Eur. J. Org. Chem.</source>
<year>2008</year>, <volume>2008</volume>, <fpage>3678</fpage>&#x02013;<lpage>3688</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.200800340</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit16d"><label> d</label><name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Sharma</surname><given-names>U. K.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Sharma</surname><given-names>N.</given-names></name>; <name><surname>Harvey</surname><given-names>J. N.</given-names></name>; <name><surname>Van der Eycken</surname><given-names>E. V.</given-names></name>
<article-title>Diversity-Oriented Synthesis of &#x003b2;-Lactams and
&#x003b3;-Lactams by Post-Ugi Nucleophilic Cyclization: Lewis Acids
as Regioselective Switch</article-title>. <source>Eur. J. Org. Chem.</source>
<year>2015</year>, <volume>2015</volume>, <fpage>3957</fpage>&#x02013;<lpage>3962</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201500270</pub-id>.</mixed-citation></ref></ref-list></back></article>